Skip to main content
. 2017 Sep 14;12(9):e0184753. doi: 10.1371/journal.pone.0184753

Fig 2. Elevated circulating levels of cathelicidin and HBD2 in bilateral and cavitary disease in PTB-DM individuals and relationship to bacterial burden.

Fig 2

(A) The plasma levels of cathelicidin (LL37), HBD2, HNP1-3 and granulysin were measured in PTB-DM individuals with bilateral vs unilateral disease. (B) The plasma levels of cathelicidin (LL37), HBD2, HNP1-3 and granulysin were measured in PTB-DM individuals with cavitary vs non-cavitary disease. (C) The relationship between the plasma levels of cathelicidin (LL37), HBD2, HNP1-3 and granulysin and smear grades as estimated by sputum smears was examined in PTB-DM individuals. The data are presented as scatter plots with each circle representing a single individual. P values were calculated using the Mann-Whitney test or the Linear trend post—test.